TWEAK/Fn14 promotes oxidative stress through AMPK/PGC1α/MnSOD signaling pathway in endothelial cells

Hengdao Liu1, Hui Peng1, Hong Xiang1

  • 1Center for Experimental Medical Research, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.

Molecular Medicine Reports
|December 20, 2017
PubMed

Insights

Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) increases reactive oxygen species (ROS) and mitochondrial ROS (mtROS) in endothelial cells, impairing nitric oxide (NO) production. This dysfunction involves the TWEAK/Fn14 pathway and the AMPK/PGC-1α/MnSOD signaling cascade.

Area of Science:

  • Endothelial cell biology
  • Molecular mechanisms of cell dysfunction
  • Oxidative stress research

Background:

  • Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is known to cause endothelial cell dysfunction via its receptor, Fn14.
  • The specific role of TWEAK/Fn14 in regulating reactive oxygen species (ROS), particularly mitochondrial ROS (mtROS), and nitric oxide (NO) production in endothelial cells is not fully understood.

Purpose of the Study:

  • To investigate the impact of the TWEAK/Fn14 pathway on ROS, mtROS, and NO generation in human umbilical vein endothelial cells (HUVECs).
  • To elucidate the underlying molecular mechanisms, including the involvement of the AMP-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α)/manganese superoxide dismutase (MnSOD) signaling pathway.

Main Methods:

  • Human umbilical vein endothelial cells (HUVECs) were treated with TWEAK and Fn14 small interfering (si)RNA or control RNA.
  • ROS and mtROS production were assessed using fluorescent microscopy and flow cytometry.
  • Nitric Oxide (NO) levels were measured using a Nitric Oxide Assay kit.
  • Mitochondrial DNA (mtDNA) damage was quantified via polymerase chain reaction (PCR).
  • Protein expression levels of active AMPK, PGC-1α, and MnSOD were analyzed.

Main Results:

  • TWEAK significantly increased ROS and mtROS production and aggravated mtDNA damage in HUVECs.
  • TWEAK treatment led to a decrease in NO generation.
  • Inhibition of Fn14 using siRNA counteracted TWEAK-induced ROS and mtROS production and mtDNA damage, while restoring NO levels.
  • TWEAK inhibited the expression of active AMPK, PGC-1α, and MnSOD; Fn14 siRNA reversed these inhibitory effects.

Conclusions:

  • The TWEAK/Fn14 pathway contributes to endothelial dysfunction by modulating ROS and mtROS production.
  • The underlying mechanism involves the disruption of the AMPK/PGC-1α/MnSOD signaling pathway.
  • Targeting the TWEAK/Fn14 interaction may offer a therapeutic strategy for endothelial dysfunction associated with oxidative stress.